browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
3c1e23be-be49-438a-825c-0a588055a1dd
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-23 14:51:26
Income (reported)
—
Expenses (reported)
$92,304
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

LUPIN PHARMACEUTICALS INC

Pharmaceutical Manufacturing

Contact
SHAWN BROWN
Phone
+1 301-437-0287
Address
zip:20912, city:Takoma Park, state:MD, street:721 Erie Ave Apt 5
Client

LUPIN PHARMACEUTICALS INC

State
MD
Country
US
Government-entity client
false
Effective date
2018-01-02
Issues lobbied + lobbyists (4)

HCR — Health Issues

Patent Thickets, Interchangeability of biosimilars, Clinical Trials exemption for biosimilars, "Net Effective Cost" PBM reform, Country of Origin labeling, Abbreviated Drug Labeling, Tariffs, Domestic Manufacturing, DSCSA.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Reimbursement of generic pharmaceuticals and biosimilars.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

PHA — Pharmacy

Country of Origin labeling.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MAN — Manufacturing

Incentivizing domestic manufacturing of essential medicines.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.